secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001654954-24-003318
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q1 revenue down 44% to $2.4M; swings to net loss of $270.7K
---------------------------------------------------------------------------

- Revenue for Q1 ended Jan 31, 2024: $2.4M, down $1.9M from $4.3M in prior-year quarter.
- Net loss of ~$270.7K vs net income of $426.4K in the same quarter last year.
- CEO cites planned investments in business development to drive future growth and profitability.
- No specific financial guidance or outlook provided for fiscal year 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424003318/0001654954-24-003318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424003318/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-003318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer